Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands |
12 Months Ended |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Revenues: |
|
|
| Product sales |
$ 7,381
|
$ 3,868
|
| Other revenue |
348
|
76
|
| Total revenues |
7,729
|
3,944
|
| Cost of revenues |
|
|
| Products and services |
4,987
|
2,601
|
| Product line exit expense |
747
|
0
|
| Total cost of revenues |
5,734
|
2,601
|
| Gross profit |
1,995
|
1,343
|
| Operating expenses: |
|
|
| Selling, general and administrative |
20,276
|
11,631
|
| Research and development |
6,214
|
2,789
|
| Total operating expenses |
26,490
|
14,420
|
| Loss from operations |
(24,495)
|
(13,077)
|
| Other income (expense): |
|
|
| Investment income |
31
|
83
|
| Debt forgiveness income |
0
|
417
|
| Other |
15
|
(3)
|
| Nonoperating Income (Expense), Total |
46
|
497
|
| Net loss |
$ (24,449)
|
$ (12,580)
|
| Net loss per basic and diluted common share (in dollars per share) |
$ (0.62)
|
$ (0.37)
|
| Weighted average common shares used to compute net loss per basic and diluted common share (in shares) |
39,281,620
|
33,846,338
|
| Comprehensive loss: |
|
|
| Net loss |
$ (24,449)
|
$ (12,580)
|
| Net unrealized gain (loss) on short-term investments |
(21)
|
15
|
| Comprehensive loss |
$ (24,470)
|
$ (12,565)
|